Angion Biomedica Enters into a Strategic Partnership with Vifor Pharma
November 9, 2020 – BusinessWire – FLG Partner client, Angion Biomedica and Vifor Pharma have signed a license agreement for ANG-3777 in nephrology indications. Through this strategic partnership, Vifor Pharma acquires a worldwide license, excluding Greater China, to late-stage product ANG-3777. ANG-3777 is a first in class small-molecule hepatocyte growth…Read More
Read MoreHuman API Closes $20M Series C
Human API, a San Mateo, California-based company developing an AI pipeline that structures health data into a standardized format, this week raised over $20 million. A spokesperson for the startup says the capital will be used to scale new products and services that support product design, risk stratification, clinical trial…Read More
Read MoreLark Closes $55M Series C Followed by $15M in Debt Facilities
MOUNTAIN VIEW, Calif., Oct. 8, 2020 /PRNewswire/ — Lark Health today announced it has closed a $55 million Series C funding round led by King River Capital, as well as a $15 million venture debt credit facility with Trinity Capital and Bridge Bank. The round also includes new investors Franklin Templeton, SteelSky Ventures, and Olive Tree Capital; and…Read More
Read MoreFox Acquires Tubi for $0.5B
NEW YORK and LOS ANGELES, April 20, 2020 /PRNewswire/ — Fox Corporation (Nasdaq: FOXA, FOX) today announced that it has completed its acquisition of Tubi, Inc. The completion of the transaction follows the satisfaction of all customary closing conditions. Full press release here.
Read MoreIridex Corp. (NASDAQ: IRIX) Engages FLG Partners
March 30, 2020 – IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that Romeo Dizon has retired from his position as Vice President of Finance, effective March 27, 2020. Mr. Dizon has agreed to continue to…Read More
Read More